Fibrosing interstitial lung diseases involve different pathogenic pathways with similar outcomes

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 32, Issue 3, 2015, Pages 246-250

  Vasakova, Martina ^a   Poletti, Venerino ^b  

^a Department of Respiratory Medicine Thomayer Hospital ^*  (Czech Republic)

^b MORGAGNI PIERANTONI HOSPITAL   (Italy)

Author keywords

Diagnosis; Pathogenesis; Pulmonary fibrosis; Treatment

Indexed keywords

ALLERGIC PNEUMONITIS; ARTICLE; CLINICAL FEATURE; CLINICAL RESEARCH; CONNECTIVE TISSUE DISEASE; FIBROSING ALVEOLITIS; FIBROSING INTERSTITIAL LUNG DISEASE; HUMAN; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; OUTCOME ASSESSMENT; PNEUMOCONIOSIS; PRIORITY JOURNAL; SARCOIDOSIS; ANIMAL; COMBINATION DRUG THERAPY; DRUG EFFECTS; LUNG; PATHOLOGY; PREDICTIVE VALUE; PULMONARY FIBROSIS; RISK FACTOR; TREATMENT OUTCOME;

ANTIINFLAMMATORY AGENT; IMMUNOSUPPRESSIVE AGENT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; DRUG THERAPY, COMBINATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG; PREDICTIVE VALUE OF TESTS; PULMONARY FIBROSIS; RISK FACTORS; TREATMENT OUTCOME;

EID: 84941635498     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Sisson TH, Mendez M, Choi K, Subbotina N, Courey A, Cunningham A, Dave A, Engelhardt JF, Liu X, White ES, Thannickal VJ, Moore BB, Christensen PJ, Simon RH. Targeted injury of type II alveolar epithelial cells induces pulmonary fibrosis. Am J Respir Crit Care Med 2010 Feb 1; 181 (3): 254-63. doi: 10. 1164/rccm. 200810-1615 OC. Epub 2009 Oct 22.
2. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE Jr, Kondoh Y, Myers J, Müller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Schünemann HJ; ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011 Mar 15; 183 (6): 788-824. doi: 10. 1164/rccm. 2009-040GL.
3. Königshoff M, Kramer M, Balsara N, Wilhelm J, Amarie OV, Jahn A, Rose F, Fink L, Seeger W, Schaefer L, Günther A, Eickelberg O. WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis. J Clin Invest 2009 Apr; 119 (4): 772-87. doi: 10. 1172/JCI 33950. Epub 2009 Mar 16.
4. Aumiller V, Balsara N, Wilhelm J, Günther A, Königshoff M. WNT/b-catenin signaling induces IL-1b expression by alveolar epithelial cells in pulmonary fibrosis. Am J Respir Cell Mol Biol 2013 Jul; 49 (1): 96-104. doi: 10. 1165/rcmb. 2012-0524OC.
5. Chilosi M, Poletti V, Zamò A, Lestani M, Montagna L, Piccoli P, Pedron S, Bertaso M, Scarpa A, Murer B, Cancellieri A, Maestro R, Semenzato G, Doglioni C. Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis. Am J Pathol 2003 May; 162 (5): 1495-502
6. Henderson WR Jr, Chi EY, Ye X, Nguyen C, Tien YT, Zhou B, Borok Z, Knight DA, Kahn M. Inhibition of Wnt/beta-catenin/ CREB binding protein (CBP) signaling reverses pulmonary fibrosis. Proc Natl Acad Sci USA. 2010 Aug 10; 107 (32): 14309-14. doi: 10. 1073/pnas. 1001520107. Epub 2010 Jul 21.
7. Hecker L, Logsdon NJ, Kurundkar D, Kurundkar A, Bernard K, Hock T, Meldrum E, Sanders YY, Thannickal VJ. Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance. Sci Transl Med 2014 Apr 9; 6 (231): 231ra47. doi: 10. 1126/scitrans lmed. 3008182.
8. Thannickal VJ, Loyd JE. Idiopathic pulmonary fibrosis: A disorder of lung regeneration? Am J Respir Crit Care Med 2008 Oct 1; 178 (7): 663-5. doi: 10. 1164/rccm. 200807-1127ED.
9. Hecker L, Thannickal VJ. Nonresolving fibrotic disorders: idiopathic pulmonary fibrosis as a paradigm of impaired tissue regeneration. Am J Med Sci 2011 Jun; 341 (6): 431-4. doi: 10. 1097/MAJ. 0b013e 31821a9d66. Review.
10. Lawson WE, Loyd JE, Degryse AL. Genetics in pulmonary fibrosisfamilial cases provide clues to the pathogenesis of idiopathic pulmonary fibrosis. Am J Med Sci 2011 Jun; 341 (6): 439-43. doi: 10. 1097/MAJ. 0b013e31821a9d7a.
11. Seibold MA, Wise AL, Speer MC, Steele MP, Brown KK, Loyd JE, Fingerlin TE, Zhang W, Gudmundsson G, Groshong SD, Evans CM, Garantziotis S, Adler KB, Dickey BF, du Bois RM, Yang IV, Herron A, Kervitsky D, Talbert JL, Markin C, Park J, Crews AL, Slifer SH, Auerbach S, Roy MG, Lin J, Hennessy CE, Schwarz MI, Schwartz DA. A common MUC5B promoter polymorphism and pulmonary fibrosis. N Engl J Med 2011 Apr 21; 364 (16): 1503-12. doi: 10. 1056/NEJMoa1013660.
12. Vasakova M, Sterclova M, Matej R, Olejar T, Kolesar L, Skibova J, Striz I. IL-4 polymorphisms, HRCT score and lung tissue markers in idiopathic pulmonary fibrosis. Hum Immunol 2013 Oct; 74 (10): 1346-51. doi: 10. 1016/j. humimm. 2013. 07. 011. Epub 2013 Jul 31.
13. Romagnoli M, Nannini C, Piciucchi S, Girelli F, Gurioli C, Casoni G, Ravaglia C, Tomassetti S, Gurioli Ch, Gavelli G, Carloni A, Dubini A, Cantini F, Chilosi M, Poletti V. Idiopathic nonspecific interstitial pneumonia: An interstitial lung disease associated with autoimmune disorders? Eur Respir J 2011 Aug; 38 (2): 384-91. doi: 10. 1183/09031936. 00094910. Epub 2011 Jan 27.
14. Takahashi M, Kunugi S, Terasaki Y, Terasaki M, Urushiyama H, Kuwahara N, Wakamatsu K, Nakayama T, Fukuda Y. The difference of neovascularization in early intra-alveolar fibrosis between nonspecific interstitial pneumonia and usual interstitial pneumonia. Pathol Int 2013 May; 63 (5): 237-44. doi: 10. 1111/pin. 12058.
15. Kang BH, Park JK, Roh JH, Song JW, Lee CK, Kim M, Jang SJ, Colby TV, Kim DS. Clinical significance of serum autoantibodies in idiopathic interstitial pneumonia. J Korean Med Sci 2013 May; 28 (5):731-7. doi: 10. 3346/jkms. 2013. 28. 5. 731. Epub 2013 May 2.
16. Selman M, Buendía-Roldán I. Immunopathology, diagnosis, and management of hypersensitivity pneumonitis. Semin Respir Crit Care Med 2012 Oct; 33 (5): 543-54. Epub 2012 Sep 21.
17. Sterclova M, Matej R, Mandakova P, Skibova J, Vasakova M. Role of interleukin 4 and its receptor in clinical presentation of chronic extrinsic allergic alveolitis: A pilot study. Multidiscip Respir Med 2013 May 30; 8 (1): 35. doi: 10. 1186/2049-6958-8-35.
18. Cox-Ganser JM, Burchfiel CM, Fekedulegn D, Andrew ME, Ducatman BS. Silicosis in lymph nodes: The canary in the miner? J Occup Environ Med 2009 Feb; 51 (2): 164-9. doi: 10. 1097/ JOM. 0b013e31818f6a0f.
19. Robalo Cordeiro C, Alfaro TM, Freitas S, Cemlyn-Jones J, Ferreira AJ. Rare interstitial lung diseases of environmental origin. Eur Respir Mon 2011, 54: 301-16.
20. Nakamura Y, Chida K, Suda T, Hayakawa H, Iwata M, Imokawa S, Tsuchiya T, Ida M, Gemma H, Yasuda K, Yagi T, Shirai T, Tamura R, Nakano Y, Hirata T, Nakamura H, Colby TV. Nonspecific interstitial pneumonia in collagen vascular diseases: comparison of the clinical characteristics and prognostic significance with usual interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis 2003 Oct; 20 (3): 235-41.
21. Kim EJ, Elicker BM, Maldonado F, Webb WR, Ryu JH, Van Uden JH, Lee JS, King TE Jr, Collard HR. Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J 2010 Jun; 35 (6): 1322-8. doi: 10. 1183/09031936. 00092309. Epub 2009 Dec 8.
22. Antoniou KM, Walsh SL, Hansell DM, Rubens MR, Marten K, Tennant R, Hansel T, Desai SR, Siafakas NM, du Bois RM, Wells AU. Smoking-related emphysema is associated with idiopathic pulmonary fibrosis and rheumatoid lung. Respirology 2013 Nov; 18 (8): 1191-6. doi: 10. 1111/resp. 12154.
23. Xu L, Kligerman S, Burke A. End-stage sarcoid lung disease is distinct from usual interstitial pneumonia. Am J Surg Pathol. 2013 Apr;37(4):593-600. doi: 10. 1097/PAS. 0b013e3182785a2d.
24. Camus P, Bonniaud P, Fanton A, Camus C, Baudaun N, Foucher P. Drug-induced and iatrogenic infiltrative lung disease. Clin Chest Med. 2004 Sep; 25 (3): 479-519, vi. Review.
25. Casoni GL, Tomassetti S, Cavazza A, Colby TV, Dubini A, Ryu JH, Carretta E, Tantalocco P, Piciucchi S, Ravaglia C, Gurioli C, Romagnoli M, Gurioli C, Chilosi M, Poletti V. Transbronchial lung cryobiopsy in the diagnosis of fibrotic interstitial lung diseases. PLoS One. 2014 Feb 28; 9 (2): e86716. doi: 10. 1371/journal. pone. 0086716. eCollection 2014.
26. Richeldi L. Treatments for idiopathic pulmonary fibrosis. N Engl J Med 2014 Aug 21; 371 (8): 783. doi: 10. 1056/NEJMc1407776.
27. Maher TM Idiopathic pulmonary fibrosis: pathobiology of novel approaches to treatment. Clin Chest Med 2012; 33: 69-83.